(Q54592005)

1 June 2018

title

Chronic cardiac pressure overload induces adrenal medulla hypertrophy and increased catecholamine synthesis. (English)

1 reference

1 June 2018

author

Ralf Gilsbach

4

1 reference

1 June 2018

author name string

Johanna Schneider

1

1 reference

1 June 2018

Achim Lother

2

1 reference

1 June 2018

Lutz Hein

3

1 reference

1 June 2018

publication date

10 March 2011

1 reference

1 June 2018

Basic Research in Cardiology

published in

1 reference

1 June 2018

volume

106

1 reference

1 June 2018

issue

4

1 reference

1 June 2018

page(s)

591-602

1 reference

1 June 2018

https://scigraph.springernature.com/pub.10.1007/s00395-011-0166-z

exact match

0 references

cites work

Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

Biomarkers in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

Differential control of adrenal and sympathetic catecholamine release by alpha 2-adrenoceptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

Feedback inhibition of catecholamine release by two different alpha2-adrenoceptor subtypes prevents progression of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

Characterization of the GNAQ promoter and association of increased Gq expression with cardiac hypertrophy in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

Heterozygous alpha 2C-adrenoceptor-deficient mice develop heart failure after transverse aortic constriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

Sympathetic alpha(2)-adrenoceptors prevent cardiac hypertrophy and fibrosis in mice at baseline but not after chronic pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

Hypothalamic-pituitary-adrenal response to chronic stress in five inbred rat strains: differential responses are mainly located at the adrenocortical level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

Adrenal corticomedullary hyperplasia in hypobaric hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

Regulation by phosphodiesterase isoforms of protein kinase A-mediated attenuation of myocardial protein kinase D activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

Adverse consequences of high sympathetic nervous activity in the failing human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

Molecular and cellular mechanisms of cardiac arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

Regulation and role of the presynaptic and myocardial Na+/H+ exchanger NHE1: effects on the sympathetic nervous system in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

Adrenal GRK2 lowering is an underlying mechanism for the beneficial sympathetic effects of exercise training in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

Conserved expression and functions of PDE4 in rodent and human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

Seven-transmembrane-spanning receptors and heart function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

Nicotinic acetylcholine receptors of adrenal chromaffin cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

A histamine H₂ receptor blocker ameliorates development of heart failure in dogs independently of β-adrenergic receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

Mechanisms of sympathetic activation in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

Altered function and regulation of cardiac ryanodine receptors in cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

Neural regulation of phenylethanolamine N-methyltransferase in vivo: transcriptional and translational changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

Stress and the adrenocortical control of epinephrine synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

Steroid receptor regulated transcription of specific genes and gene networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0166-Z

10.1007/S00395-011-0166-Z

21 January 2018

Identifiers

DOI

1 reference

1 June 2018

PubMed ID

21547520

1 reference

1 June 2018